Tokyo, Japan, Jan 26, 2007 - (JCN Newswire) - Pfizer Japan Inc. and Astellas Pharma Inc. announced that a settlement has been reached today by Pfizer, Pfizer's affiliate, and Astellas, which are the parties to a Development and Marketing Agreement for a hypercholesterolemia drug "Lipitor(R)" manufactured and distributed by Astellas and promoted jointly by Pfizer and Astellas in Japan (the "DMA") on a declaratory judgment action filed by Astellas to confirm that the term of DMA shall continue until July 8, 2016.
The action was filed by Astellas on November 7, 2006 at the Tokyo District Court.
The settlement agreement contains the following conditions:
- The DMA is amended to the effect that the term of DMA will expire on July 8, 2016.
- All other terms and conditions of the DMA will remain unchanged.
- Astellas will withdraw the declaratory judgment action.
The settlement involves no payment from either party to the other. Pfizer and Astellas are pleased with the prompt resolution of this issue, and are committed to the marketing and promotion of Lipitor in Japan with a renewed focus.
About Astellas Pharma Inc.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. In April 2005, the company was formed through the merger of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. The organization is committed to becoming a global mega pharmaceutical company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. For more information on Astellas Pharma Inc., please visit the company's website at www.astellas.com.
Source: Astellas Pharma Inc.
Contact:
Astellas Pharma Inc.
Corporate Communications
Tel: +81-3-3244-3201 Fax: +81-3-5201-7473
http://www.astellas.com
Pfizer Japan Inc.
Corporate Communications
Tel: +81-3-5309-7201 Fax: +81-3-5309-9004
http://www.pfizer.co.jp
Copyright [c] 2007 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K.
COPYRIGHT 2007 Japan Corporate News Network K.K.
COPYRIGHT 2007 Gale Group
JCN Newswires
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment